Cytopathologic Features Indicative of 5‐Hydroxytryptamine Axon Degeneration Are Observed in Rat Brain after Administration of d‐ and l‐Methylenedioxyamphetaminea
Data up to Jan 2025
Total Citations Per Year
Abstract
References (9)
Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity
1988 • 548 citations
Effects of enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices
1986 • 312 citations
Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class
1986 • 187 citations
Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors
1990 • 134 citations
Anatomic evidence for a neurotoxic effect of (±)-fenfluramine upon serotonergic projections in the rat
1990 • 121 citations
3,4-Methylenedioxymethamphetamine (MDMA): Stereoselective interactions at brain 5-HT1 and 5-HT2 receptors
1986 • 119 citations
Further investigation of the discriminative stimulus properties of MDA
1984 • 105 citations
Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat.
1988 • 61 citations
Similarities between aberrant serotonergic fibers in the aged and 5,7-DHT denervated young adult rat brain
1989 • 46 citations